113 related articles for article (PubMed ID: 15517230)
1. Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer.
Morgia G; Falsaperla M; Malaponte G; Madonia M; Indelicato M; Travali S; Mazzarino MC
Urol Res; 2005 Feb; 33(1):44-50. PubMed ID: 15517230
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase 9 immunostaining profile is positively correlated with tumor grade, extraprostatic extension and biochemical recurrence in prostate cancer.
Pinheiro LCL; Pereira ÉR; Francelino AL; Guembarovski AFML; Fuganti PE; de Oliveira KB; Miqueloto CA; Serpeloni JM; Guembarovski RL
Pathol Res Pract; 2024 Jan; 253():155024. PubMed ID: 38113764
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases targeting in prostate cancer.
Zhu S; He J; Yin L; Zhou J; Lian J; Ren Y; Zhang X; Yuan J; Wang G; Li X
Urol Oncol; 2024 May; ():. PubMed ID: 38806387
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of E-cadherin and MMP-13 in prostate cancer patients: correlation with PSA, testosterone and pathological parameters.
Bonaldi CM; Azzalis LA; Junqueira VB; de Oliveira CG; Vilas Boas VA; Gáscon TM; Gehrke FS; Kuniyoshi RK; Alves BC; Fonseca FL
Tumori; 2015; 101(2):185-8. PubMed ID: 25733385
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
[TBL] [Abstract][Full Text] [Related]
6. Natural Products as Regulators against Matrix Metalloproteinases for the Treatment of Cancer.
Islam MT; Jang NH; Lee HJ
Biomedicines; 2024 Apr; 12(4):. PubMed ID: 38672151
[TBL] [Abstract][Full Text] [Related]
7. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.
Samaržija I
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255186
[TBL] [Abstract][Full Text] [Related]
8. Association of
Akter T; Aziz MA; Islam MS; Sarwar MS
Health Sci Rep; 2023 Oct; 6(10):e1607. PubMed ID: 37841939
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer.
Eiro N; Medina A; Gonzalez LO; Fraile M; Palacios A; Escaf S; Fernández-Gómez JM; Vizoso FJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108185
[TBL] [Abstract][Full Text] [Related]
10. Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.
Li S; Pritchard DM; Yu LG
Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805035
[TBL] [Abstract][Full Text] [Related]
11. A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology.
Athanasiou A; Tennstedt P; Wittig A; Huber R; Straub O; Schiess R; Steuber T
PLoS One; 2021; 16(11):e0259093. PubMed ID: 34767586
[TBL] [Abstract][Full Text] [Related]
12. Sublethal doxorubicin promotes migration and invasion of breast cancer cells: role of Src Family non-receptor tyrosine kinases.
Mohammed S; Shamseddine AA; Newcomb B; Chavez RS; Panzner TD; Lee AH; Canals D; Okeoma CM; Clarke CJ; Hannun YA
Breast Cancer Res; 2021 Jul; 23(1):76. PubMed ID: 34315513
[TBL] [Abstract][Full Text] [Related]
13. Generalized Score Matching for Non-Negative Data.
Yu S; Drton M; Shojaie A
J Mach Learn Res; 2019 Apr; 20():. PubMed ID: 34290571
[TBL] [Abstract][Full Text] [Related]
14. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in
Białkowska K; Marciniak W; Muszyńska M; Baszuk P; Gupta S; Jaworska-Bieniek K; Sukiennicki G; Durda K; Gromowski T; Lener M; Prajzendanc K; Łukomska A; Cybulski C; Huzarski T; Gronwald J; Dębniak T; Lubiński J; Jakubowska A
Hered Cancer Clin Pract; 2020; 18():16. PubMed ID: 32765800
[TBL] [Abstract][Full Text] [Related]
16. Selected Matrix Metalloproteinases (MMP-2, MMP-7) and Their Inhibitor (TIMP-2) in Adult and Pediatric Cancer.
Kaczorowska A; Miękus N; Stefanowicz J; Adamkiewicz-Drożyńska E
Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32751899
[TBL] [Abstract][Full Text] [Related]
17. miR-330 Regulates Colorectal Cancer Oncogenesis by Targeting BACH1.
Shirjang S; Mansoori B; Mohammadi A; Shajari N; H G Duijf P; Najafi S; Abedi Gaballu F; Nofouzi K; Baradaran B
Adv Pharm Bull; 2020 Jul; 10(3):444-451. PubMed ID: 32665904
[No Abstract] [Full Text] [Related]
18. RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN.
Hua X; Liu Z; Zhou M; Tian Y; Zhao PP; Pan WH; Li CX; Huang XX; Liao ZX; Xian Q; Chen B; Hu Y; Leng L; Fang XW; Yu LN
EBioMedicine; 2019 Dec; 50():178-190. PubMed ID: 31727599
[TBL] [Abstract][Full Text] [Related]
19. Ras suppressor-1 (RSU-1) promotes cell invasion in aggressive glioma cells and inhibits it in non-aggressive cells through STAT6 phospho-regulation.
Louca M; Stylianou A; Minia A; Pliaka V; Alexopoulos LG; Gkretsi V; Stylianopoulos T
Sci Rep; 2019 May; 9(1):7782. PubMed ID: 31123330
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
